ConductScience.org, home

Paper18560412

Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.

Bonanomi S and 10 others. Bone Marrow Transplant, 2008. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy. Papers, record 18560412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18560412

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Successful outcome of allo-SCT in high-risk pediatric AML using chemotherapy-only conditioning and post transplant immunotherapy.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.11
iCite
Revised in PubMed
2026-10-10
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonanomi SS
2Bonnanomi SS
3Connor PP
4Webb DD
5Ancliff PP
6Amrolia PP
7Rao KK
8McCloskey DD
9Hemmatpour SS
10Goulden NN
11Veys PP

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Leukemia, Myeloid, AcuteMajor topic
Stem Cell TransplantationMajor topic
Transplantation ConditioningMajor topic
Alemtuzumab
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Busulfan
Child
Child, Preschool
Combined Modality Therapy
Cyclophosphamide
Cyclosporine
Female
Graft vs Host Disease
Humans
Immunotherapy
Infant
Male
Melphalan
Transplantation Chimera
Transplantation, Homologous

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114751924Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival.Blood2004https://conductscience.org/library/papers/14751924PubMed
214662323
Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?
Exp Hematol2003https://conductscience.org/library/papers/14662323PubMed
317374741Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.Blood2007https://conductscience.org/library/papers/17374741PubMed
416304572Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.Leukemia2005https://conductscience.org/library/papers/16304572PubMed
58201385
Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
J Clin Oncol1994https://conductscience.org/library/papers/8201385PubMed
616155933Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.Pediatr Blood Cancer2006https://conductscience.org/library/papers/16155933PubMed
711133742A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.Blood2001https://conductscience.org/library/papers/11133742PubMed
814990984Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective.Bone Marrow Transplant2004https://conductscience.org/library/papers/14990984PubMed
916878146Final height and gonad function after total body irradiation during childhood.Bone Marrow Transplant2006https://conductscience.org/library/papers/16878146PubMed
1015367433Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen.Blood2005https://conductscience.org/library/papers/15367433PubMed
1116425264The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen.Pediatr Blood Cancer2006https://conductscience.org/library/papers/16425264PubMed
1217278259Improved outcome after relapse in children with acute myeloid leukaemia.Br J Haematol2007https://conductscience.org/library/papers/17278259PubMed
139384480Early cyclosporine taper in high-risk sibling allogeneic bone marrow transplants.Bone Marrow Transplant1997https://conductscience.org/library/papers/9384480PubMed
147606014Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone.Blood1995https://conductscience.org/library/papers/7606014PubMed
1512393725Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.Blood2003https://conductscience.org/library/papers/12393725PubMed
169359499Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission.Br J Haematol1997https://conductscience.org/library/papers/9359499PubMed
172668871Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy.Percept Mot Skills1989https://conductscience.org/library/papers/2668871PubMed
1815937497Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?Bone Marrow Transplant2005https://conductscience.org/library/papers/15937497PubMed
194153799Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.Transplantation1974https://conductscience.org/library/papers/4153799PubMed
2015353481Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.Blood2005https://conductscience.org/library/papers/15353481PubMed

See all 23 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
28218757Allogeneic stem cell transplantation for refractory acute myeloid leukemia in pediatric patients: the UK experience.Bone Marrow Transplant2017https://conductscience.org/library/papers/28218757PubMed
19947897Immune-based therapeutics for pediatric cancer.Expert Opin Biol Ther2010https://conductscience.org/library/papers/19947897PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18560412

GET https://conductscience.org/api/papers/v1/18560412/references?page=2